DSM Capital Partners LLC bought a new position in shares of Stryker Co. (NYSE:SYK – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 112 shares of the medical technology company’s stock, valued at approximately $34,000. Other institutional investors […]
DSM Capital Partners LLC acquired a new position in Stryker Co. (NYSE:SYK – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 112 shares of the medical technology company’s stock, valued at approximately $34,000. Other institutional investors and hedge funds have also […]
Evermay Wealth Management LLC lifted its holdings in shares of Stryker Co. (NYSE:SYK – Free Report) by 41.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,213 shares of the medical technology company’s stock after purchasing an additional 946 […]
The Bone Graft Substitutes market is anticipated to witness significant growth, expanding from USD 3.1 billion in 2022 to USD 5.6 billion by 2032, at a CAGR of 6.2% during the forecast period from 2022 to 2032. The market growth is driven by several key factors, including the increasing prevalence of orthopedic diso.
Mitchell Sinkler & Starr PA raised its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 118.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,277 shares of the medical technology company’s stock after acquiring an additional 15,876 shares […]